A population-based incidence of M2 strokes indicates potential expansion of large vessel occlusions amenable to endovascular therapy

Abstract

BackgroundM2 occlusions may result in poor outcomes and potentially benefit from endovascular therapy. Data on the rate of M2 strokes is lacking.MethodologyPatients with acute ischemic stroke discharged over a period of 3 years from a tertiary level hospital in the ‘stroke belt’ were evaluated for M2 occlusions on baseline vascular imaging. Regional and national incidence was calculated from discharge and multicounty data.ResultsThere were 2739 ICD-9 based AIS discharges. M2 occlusions in 116 (4%, 95% CI 3.5% to 5%) patients constituted the second most common occlusion site. The median National Institute of Health Stroke Scale (NIHSS) score was 12 (IQR 5–18). Good outcomes were observed in 43% (95% CI 34% to 53%), poor outcomes in 57% (95% CI 47% to 66%), and death occurred in 27% (95% CI 19% to 37%) of patients. Receiver operating characteristics curves showed the NIHSS to be predictive of outcomes (area under the curve 0.829, 95% CI 0.745 to 0.913, p<0.0001). An NIHSS score ≥9 was the optimal cut-off point for predicting poor outcomes (sensitivity 85.7%, specificity 67.4%). 71 (61%) patients had an NIHSS score ≥9 and 45 (39%) an NIHSS score <9. The rate of good-outcome was 22.6% for NIHSS score ≥9 versus 78.4% for NIHSSscore <9 (OR=0.08, 95% CI 0.03 to 0.21, p<0.0001). Mortality was 42% for NIHSS score ≥9 versus 2.7% for NIHSS score <9 (OR=26, 95% CI 3.3 to 202, p<0.0001). Infarct volume was 57 (±55.7) cm3 for NIHSS score ≥9 versus 30 (±34)cm3 for NIHSS score <9 (p=0.003). IV recombinant tissue plasminogen activator (rtPA) administered in 28 (24%) patients did not affect outcomes. The rate of M2 occlusions was 7 (95% CI 5 to 9)/100 000 people/year (3%, 95% CI 2% to 4%), giving an incidence of 21 176 (95% CI 15 282 to 29 247)/year. Combined with M1, internal carotid artery terminus and basilar artery, this yields a ‘large vessel occlusion (LVO)+M2’ rate of 31 (95% CI 26 to 35)/100 000 people/year and a national incidence of 99 227 (95% CI 84 004 to 112 005) LVO+M2 strokes/year.ConclusionM2 occlusions can present with serious neurological deficits and cause significant morbidity and mortality. Patients with M2 occlusions and higher baseline deficits (NIHSS score ≥9) may benefit from endovascular therapy, thus potentially expanding the category of acute ischemic strokes amenable to intervention.

Endovascular clot retrieval for M2 segment middle cerebral artery occlusion: a systematic review and meta‐analysis

“…Stroke is a leading cause of adult morbidity and mortality in the developed world with an estimated incidence of 216 per 100 000 . It results in significant costs to the healthcare system, with stroke in Australia estimated to have cost $5 billion in 2012…”

“…Furthermore, these trials did not specifically describe any functional outcomes for those patients with M2 occlusions. MCA M2 occlusions can be associated with significant morbidity and mortality …”

“…The estimated incidence of M2 occlusions in the population is 7 per 100 000, with M2 segment strokes accounting for approximately 4.2% of all AIS . Multiple studies and registries have attempted to explore outcomes in patients with M2 and M3 occlusions treated with ECR .…”

The semiotics of distal thrombectomy: towards a TICI score for the target vessel

“…Evidence from randomized clinical trials continues to elucidate patient cohorts who can benefit from treatment. The time window for treatment has expanded up to 24 hours with the results from DAWN4 and DEFUSE-35 utilizing advanced imaging for triage 6. Data have also shown a potential benefit for patients presenting with larger core infarcts 7 8.…”

Moving down the tracks

“…Rai and co-authors analyzed patients with M2 thromboses, none of which were treated with MT, and calculated a population based incidence of M2 strokes 1. The authors employed non-invasive imaging, usually CT angiograpy and CT perfusion, to screen patients.…”